Listed

Kraig Biocraft Laboratories, Inc.: Form 10-K for the period ended Dec 31, 2014

Filed with the SEC on Mar 31, 2015 and accepted by EDGAR at Mar 31, 2015, 15:01 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2014-01-01 to 2014-12-31$0us-gaap:SalesRevenueNet
Research and development12 months2014-01-01 to 2014-12-31$439.5kus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2014-01-01 to 2014-12-31−$1.8mus-gaap:OperatingIncomeLoss
Interest expense12 months2014-01-01 to 2014-12-31$69.3kus-gaap:InterestExpense
Income tax12 months2014-01-01 to 2014-12-31$0us-gaap:IncomeTaxExpenseBenefit
Net income12 months2014-01-01 to 2014-12-31−$1.9mus-gaap:NetIncomeLoss
Diluted EPS12 months2014-01-01 to 2014-12-31$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2014-01-01 to 2014-12-31−$904.6kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2014-01-01 to 2014-12-31$41.8kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2014-12-31$495.0kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-12-31$496.0kus-gaap:AssetsCurrent
Total assetsAt period end2014-12-31$539.2kus-gaap:Assets
Current liabilitiesAt period end2014-12-31$1.8mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2014-12-31−$1.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001354488-15-001479. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.